130 related articles for article (PubMed ID: 17349783)
1. Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma.
Peet AC; Davies NP; Ridley L; Brundler MA; Kombogiorgas D; Lateef S; Natarajan K; Sgouros S; MacPherson L; Grundy RG
Eur J Cancer; 2007 Apr; 43(6):1037-44. PubMed ID: 17349783
[TBL] [Abstract][Full Text] [Related]
2. Added value of magnetic resonance spectroscopy for diagnosing childhood cerebellar tumours.
Davies NP; Rose HEL; Manias KA; Natarajan K; Abernethy LJ; Oates A; Janjua U; Davies P; MacPherson L; Arvanitis TN; Peet AC
NMR Biomed; 2022 Feb; 35(2):e4630. PubMed ID: 34647377
[No Abstract] [Full Text] [Related]
3. Magnetic resonance spectroscopy in posterior fossa tumours: the tumour spectroscopic signature may improve discrimination in adults among haemangioblastoma, ependymal tumours, medulloblastoma, and metastasis.
Mora P; Pons A; Cos M; Camins A; Muntané A; Aguilera C; Arús C; Majós C
Eur Radiol; 2019 Jun; 29(6):2792-2801. PubMed ID: 30569184
[TBL] [Abstract][Full Text] [Related]
4. ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.
Hekmatyar SK; Wilson M; Jerome N; Salek RM; Griffin JL; Peet A; Kauppinen RA
Br J Cancer; 2010 Oct; 103(8):1297-304. PubMed ID: 20842126
[TBL] [Abstract][Full Text] [Related]
5. MR diffusion imaging and 1H spectroscopy in a child with medulloblastoma. A case report.
Wilke M; Eidenschink A; Müller-Weihrich S; Auer DP
Acta Radiol; 2001 Jan; 42(1):39-42. PubMed ID: 11167330
[TBL] [Abstract][Full Text] [Related]
6. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS.
Davies NP; Wilson M; Harris LM; Natarajan K; Lateef S; Macpherson L; Sgouros S; Grundy RG; Arvanitis TN; Peet AC
NMR Biomed; 2008 Oct; 21(8):908-18. PubMed ID: 18613254
[TBL] [Abstract][Full Text] [Related]
8. MRS water resonance frequency in childhood brain tumours: a novel potential biomarker of temperature and tumour environment.
Babourina-Brooks B; Wilson M; Arvanitis TN; Peet AC; Davies NP
NMR Biomed; 2014 Oct; 27(10):1222-9. PubMed ID: 25125325
[TBL] [Abstract][Full Text] [Related]
9. The use of short-echo-time 1H MRS for childhood cerebellar tumours prior to histopathological diagnosis.
Harris LM; Davies N; Macpherson L; Foster K; Lateef S; Natarajan K; Sgouros S; Brundler MA; Arvanitis TN; Grundy RG; Peet AC
Pediatr Radiol; 2007 Nov; 37(11):1101-9. PubMed ID: 17823793
[TBL] [Abstract][Full Text] [Related]
10. Retinal vasoproliferative tumour in an adolescent who had medulloblastoma: a case report.
Marcelo-Tan MC; Parsons HM
Can J Ophthalmol; 2015 Oct; 50(5):e74-8. PubMed ID: 26455986
[No Abstract] [Full Text] [Related]
11. Characterisation of paediatric brain tumours by their MRS metabolite profiles.
Gill SK; Rose HEL; Wilson M; Rodriguez Gutierrez D; Worthington L; Davies NP; MacPherson L; Hargrave DR; Saunders DE; Clark CA; Payne GS; Leach MO; Howe FA; Auer DP; Jaspan T; Morgan PS; Grundy RG; Avula S; Pizer B; Arvanitis TN; Peet AC
NMR Biomed; 2024 May; 37(5):e5101. PubMed ID: 38303627
[No Abstract] [Full Text] [Related]
12. MRI features of disseminated 'drop metastases'.
Ahmed A
S Afr Med J; 2008 Jul; 98(7):522-3. PubMed ID: 18785386
[No Abstract] [Full Text] [Related]
13. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma.
Moreno-Torres A; Martínez-Pérez I; Baquero M; Campistol J; Capdevila A; Arús C; Pujol J
Neurosurgery; 2004 Oct; 55(4):824-9; discussion 829. PubMed ID: 15458590
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma metastasizing to a breast fibroadenoma: a case report.
Brydon HL; Carey MP
Br J Neurosurg; 1991; 5(1):73-5. PubMed ID: 2021436
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.
Kaminogo M; Ishimaru H; Morikawa M; Ochi M; Ushijima R; Tani M; Matsuo Y; Kawakubo J; Shibata S
Neuroradiology; 2001 May; 43(5):353-63. PubMed ID: 11396738
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR.
Davies NP; Wilson M; Natarajan K; Sun Y; MacPherson L; Brundler MA; Arvanitis TN; Grundy RG; Peet AC
NMR Biomed; 2010 Jan; 23(1):80-7. PubMed ID: 19795380
[TBL] [Abstract][Full Text] [Related]
17. Urgent radiotherapy is effective in the treatment of metastatic medulloblastoma causing symptomatic brainstem edema.
Shapiro RH; Chang AL
Pediatr Blood Cancer; 2011 Dec; 57(6):1077-80. PubMed ID: 21755588
[TBL] [Abstract][Full Text] [Related]
18. Myelography in the assessment of children with medulloblastoma.
O'Reilly G; Hayward RD; Harkness WF
Br J Neurosurg; 1993; 7(2):183-8. PubMed ID: 8494621
[TBL] [Abstract][Full Text] [Related]
19. [Can proton magnetic resonance spectroscopy be of any value as a prognostic factor in medulloblastoma?].
Dembowska-Bagińska B; Perek D; Perek-Polnik M; Drogosiewicz M; Jurkiewicz E; Pakuła-Kościesza I; Grajkowska W; Roszkowski M
Med Wieku Rozwoj; 2003; 7(2):229-39. PubMed ID: 12878794
[TBL] [Abstract][Full Text] [Related]
20. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.
Wilson M; Davies NP; Grundy RG; Peet AC
NMR Biomed; 2009 Feb; 22(2):213-9. PubMed ID: 19067434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
